Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
NYBC calls for blood donation to meet winter needs

NYBC calls for blood donation to meet winter needs

Biogen Idec reports 2009 fourth quarter and full year earnings

Biogen Idec reports 2009 fourth quarter and full year earnings

NYBC urges people to donate blood

NYBC urges people to donate blood

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reports consolidated group sales of €1,032.8M for 2009

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Baxter International reports net income of $572M for the fourth-quarter of 2009

Baxter International reports net income of $572M for the fourth-quarter of 2009

UCSB research: Rapamycin drug, a potential treatment for ADPKD

UCSB research: Rapamycin drug, a potential treatment for ADPKD

Blood donors extend their life-saving gifts to help Haiti's earthquake victims

Blood donors extend their life-saving gifts to help Haiti's earthquake victims

Biogen Idec and Swedish Orphan Biovitrum commence dosing in rFIXFc Phase I/IIa trial for hemophilia B

Biogen Idec and Swedish Orphan Biovitrum commence dosing in rFIXFc Phase I/IIa trial for hemophilia B

AMT reaches another milestone in the official marketing authorisation process for Glybera

AMT reaches another milestone in the official marketing authorisation process for Glybera

Ipsen and Inspiration Biopharmaceuticals form strategic partnership

Ipsen and Inspiration Biopharmaceuticals form strategic partnership

Ipsen enters into partnership agreement with Inspiration Biopharmaceuticals

Ipsen enters into partnership agreement with Inspiration Biopharmaceuticals

PTC Therapeutics initiates additional clinical trial of ataluren in boys and young men with nmDBMD

PTC Therapeutics initiates additional clinical trial of ataluren in boys and young men with nmDBMD

FDA grants orphan drug exclusivity approval for Octapharma AG's wilate

FDA grants orphan drug exclusivity approval for Octapharma AG's wilate

LFB completes conversion of all acquired preferred stock

LFB completes conversion of all acquired preferred stock

AMT receives Innovation Credit to develop gene therapy treatment for DMD

AMT receives Innovation Credit to develop gene therapy treatment for DMD

Rh-negative blood supply prioritized as tri-state area braces for winter months

Rh-negative blood supply prioritized as tri-state area braces for winter months

NYBC calls for blood donation in recognition of National Blood Donor Month

NYBC calls for blood donation in recognition of National Blood Donor Month

CSL Behring awards four advocacy grants to patient organizations in the U.S.

CSL Behring awards four advocacy grants to patient organizations in the U.S.

Tel Aviv University's new Genome Analyzer fuels research dreams and tomorrow's cures

Tel Aviv University's new Genome Analyzer fuels research dreams and tomorrow's cures